Literature DB >> 28744779

Congenital fiber-type disproportion in an ambulatory rehabilitation setting : A case report.

Stefano Palma1, Mohammad Keilani1, Tim Hasenoehrl1, Clemens Ambrozy1, Sara Dana1, Thomas Sycha2, Richard Crevenna3.   

Abstract

Congenital fiber-type disproportion is a rare condition, histologically characterized by a relative type 1 fiber hypotrophy. The main clinical feature is mild-to-severe muscle weakness. In this report, we present the case of a 21-year-old patient with congenital fiber-type disproportion in an outpatient rehabilitative setting to evaluate the feasibility and results of an assessment battery, including bioimpedance analysis (BIA), dynamometry, 3D gait analysis, 6‑min walk test (6MWT), and the timed up and go test (TUG). The patient had a notable decrease in all functional scores. BIA: lean body mass, 38.4 kg (50.2 ± 5.3), body fat, 1.6% (12.4 ± 4.4); hand dynamometry: 18.5 kg left/20.0 kg right (44.8 ± 6.6); walking speed, 58 cm/s (122.7 ± 11.1), step length, 43.0 cm (61.6 ± 3.5); 6MWT: 478.5 m (638 ± 44); TUG: 9.4 s (8.1 ± 1.0). No adverse events were reported. The tests used were easily applicable in clinical routine and well tolerated by our patient.

Entities:  

Keywords:  Assessment; Case report; Congenital structural myopathy; Exercise; Gait analysis

Mesh:

Year:  2017        PMID: 28744779     DOI: 10.1007/s10354-017-0580-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  30 in total

1.  An index for quantifying deviations from normal gait.

Authors:  L M Schutte; U Narayanan; J L Stout; P Selber; J R Gage; M H Schwartz
Journal:  Gait Posture       Date:  2000-02       Impact factor: 2.840

2.  The relationship between ankle plantar flexor muscle moments and knee compressive forces in subjects with and without pain.

Authors:  M J Robon; K L Perell; M Fang; E Guererro
Journal:  Clin Biomech (Bristol, Avon)       Date:  2000-08       Impact factor: 2.063

3.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

4.  Prevalence of congenital myopathies in a representative pediatric united states population.

Authors:  Kimberly Amburgey; Nancy McNamara; Lindsey R Bennett; M Eileen McCormick; Gyula Acsadi; James J Dowling
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

5.  Do dynamic and static clinical measurements correlate with gait analysis parameters in children with cerebral palsy?

Authors:  Kaat Desloovere; Guy Molenaers; Hilde Feys; Catherine Huenaerts; Barbara Callewaert; Patricia Van de Walle
Journal:  Gait Posture       Date:  2005-11-21       Impact factor: 2.840

Review 6.  Body composition in clinical practice.

Authors:  Angela Andreoli; Francesco Garaci; Francesco Pio Cafarelli; Giuseppe Guglielmi
Journal:  Eur J Radiol       Date:  2016-02-15       Impact factor: 3.528

7.  Biomechanical gait alterations independent of speed in the healthy elderly: evidence for specific limiting impairments.

Authors:  D C Kerrigan; M K Todd; U Della Croce; L A Lipsitz; J J Collins
Journal:  Arch Phys Med Rehabil       Date:  1998-03       Impact factor: 3.966

8.  Myalgia as the revealing symptom of multicore disease and fibre type disproportion myopathy.

Authors:  C Sobreira; W Marques; A A Barreira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 9.  Congenital fiber type disproportion--30 years on.

Authors:  Nigel F Clarke; Kathryn N North
Journal:  J Neuropathol Exp Neurol       Date:  2003-10       Impact factor: 3.685

10.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Authors:  M Muscaritoli; S D Anker; J Argilés; Z Aversa; J M Bauer; G Biolo; Y Boirie; I Bosaeus; T Cederholm; P Costelli; K C Fearon; A Laviano; M Maggio; F Rossi Fanelli; S M Schneider; A Schols; C C Sieber
Journal:  Clin Nutr       Date:  2010-01-08       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.